0
0 (0%)
H-Cyte, Inc. [HCYT]
Source:
Company Overview
H-cyte, Inc is currently focusing on acquiring and developing early-stage companies or their technologies inthe areas of therapeutics, medical devices, and diagnostics. The goal is to develop these companies and incubate their technologies tomeaningful clinical inflection points.
| Country | United States |
| Headquarters | tampa, florida |
| Phone Number | 844-633-6839 |
| Industry | manufacturing |
| CEO | Michael Yurkowsky |
| Website | ir.hcyte.com |
Financial Year:
Financial Overview (Dollars in Millions)
| Revenue | $0 |
| Operating Profit | $-0.4 |
| Net Income | $0.8 |
| Net Cash | $0 |
Profit Ratios
| Gross Margin | $0 |
| Operating Margin | |
| Profit as % of Revenues | |
| Profit as % of Assets | 474.9% |
| Profit as % of Stockholder Equity | -7.9% |
Management Effectiveness
| Return on Equity | -7.9% |
| Return on Assets | 394.2% |
| Turnover Ratio | 0% |
| EBITA |
Balance Sheet and Cash Flow Measures
| Total Assets | $0.2 |
| Total Liabilities | $10.6 |
| Operating Cash Flow | $0 |
| Investing Cash Flow | |
| Financing Cash Flow | $0 |
